Subjects and Methods BMD was studied in 22 girls with Turner syndrome, aged 5 to 22 years, in relation to pubertal status and karyotype. Of the 22, 11 patients eventually developed puberty, while 4 others did not. The remaining 7 were too young to determine at the time of writing. The karyotype was monosomy X in 16 subjects and various mosaic patterns in the remaining 6. No patients had received sex hormone replacement. BMD of trabecular bones was evaluated by dual X-ray absorptiometry (DXA) of the L2-4 BMD using Hologic QDR-1,000 and that of cortical bones by IGS/D using Teijin Bonalyzer (computed X-ray densitometry; CXD). We also studied longitudinal data of six patients receiving GH, administered at a dose of 0.5 IU/kg/ week. All subjects had normal GH values before initiation of therapy. Age-matched Japanese girls were used as normal controls (4, 5). Comparisons between Turner syndrome subjects and control populations used a mean Z score; comparisons between pubertal status and karyotype used the unpaired t-test. Significance was defined as P<0.05. In skeletal age comparisons, bone age was evaluated by the method of Greulich and Pyle (6). therapy during or after adolescence.
Discussion
It has been documented that BMD is lower in Turner syndrome (2, 3). There have also been reports suggesting that osteopenia associated with this disease is not analogous to postmenopausal osteoporosis (3).
We measured trabecular and cortical BMD in Turner syndrome subjects and found them to be lower than in normal controls. Cortical bone showed severer demineralization. As females of Turner syndrome commonly have a typical lag in skeletal age of about 1-3 years relative to chronological age, BMD was adjusted for bone age. However, this did not completely eliminate the difference. Bone mineral acquisition in normal females is also strongly correlated with pubertal status, possibly due to the effects of estrogen on bone. However, in these subjects, BMD did not differ significantly between sub-Bone Mineral Status in Turner Syndrome jects who eventually developed puberty and those who did not. Up to now, the effects of estrogen upon BMD are not clear in Turner syndrome. Although there is some evidence that BMD in adults with Turner syndrome is related to estrogen therapy (7), estrogen replacement in Turner syndrome adolescents has not been clearly associated with bone mineral accretion (8). Considering that estrogen affects trabecular bone more than cortical bone and that estrogen strongly affects bone age, our results show that estrogen deficiency is not the only cause of osteopenia in this disease. Although they showed no statistically significant difference between karyotype monosomy X and other types, the osteopenia in Turner syndrome may represent an independent effect of the chromosome constitution (2) . Further evaluation with bone mineral turnover markers is required. Clinical management of children and adolescents with Turner syndrome has focused on growth therapy, and many patients now receive recombinant human GH. It is well known that GH and insulin-like growth factor-I (IGF-I) enhance bone growth per se, and several in vitro studies support the role of GH & IGF-I in bone accretion. However, there is little definite evidence that GH increases bone mineralization in vivo. Our results show that GH therapy, if initiated at an early age, improves the rate of bone mineral acquisition. Previous reports of bone mineral deficiency in Turner syndrome subjects have led to the suggestion that estrogen replacement should begin early in adolescence to prevent this complication. However, because there is serious concern that estrogen stimulates acceleration of bone age and consequently reduces final height, early estrogen replacement cannot be justified on the basis of bone mineral status during GH therapy (10).
In summary, 1) children with Turner syndrome have a decreased BMD, 2) demineralization is not always analogous to postmenopausal osteoporosis, and 3) GH may be an effective treatment for osteopenia as well as for short stature (11). 
